StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3379.TWO$40.00-3.26%
Fair $40.00+0.0%

3379.TWO

Taiwan Benefit Company

Industrials / Specialty Industrial MachineryTaipei Exchange

$40.00

-1.35 (-3.26%)

Fairly Valued+0.0%Fair Value $40.00Fund rank 32/100 · Data gapFallback financials|
SA 40/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 23%

FCF escenarios

weak_data · normalized FCF $88.7M · quality 55.3/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 35/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 3379.TWOLocal privado en este navegador · Taiwan Benefit Company
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.5B

P/E

19.0x

↑

EV/EBITDA

11.5x

↑

ROE

11.9%

↑

Gross Margin

13.2%

↓

Debt/Equity

0.06

↓
52-Week Range$40
$32$85

TradingView lightweight chart

3379.TWO price, volumen y niveles de valoración

Último $40.00Periodo +442.4%
Fair value: $40.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+50.4%

FCF CAGR

—

FCF margin

4.5%

FCF / Net income

1.10x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.98B · net income $80.7M · FCF $88.7M

2022-FY → 2025-FY

Gross margin

13.2%-6.5% pts

Operating margin

3.3%+9.3% pts

Net margin

4.1%+7.7% pts

FCF margin

4.5%+15.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.98B$1.98B$1.09B$601.4M$582.1M
Net Income$80.7M$80.7M$41.5M$-4.6M$-20.9M
EBITDA$113.0M$113.0M$56.6M$12.0M$-4.9M
EPS——1.09-0.12-0.55
Gross Margin13.2%13.2%18.0%22.3%19.7%
Operating Margin3.3%3.3%1.7%-4.0%-6.0%
Net Margin4.1%4.1%3.8%-0.8%-3.6%
Balance Sheet
Debt/Equity0.060.060.060.070.15
Current Ratio1.201.20———
Cash Flow
Free Cash Flow$88.7M$88.7M$194.9M$26.5M$-64.4M
Returns
ROE11.9%11.9%6.7%-0.8%-4.5%
Valuation
P/E18.9618.9634.59——
EV/EBITDA11.5011.5019.9541.00—
P/B2.242.242.300.990.98
Growth & Yield
Revenue Growth82.3%82.3%80.5%3.3%—
EPS Growth——1008.3%78.2%—
Dividend Yield1.9%1.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -44.7%

Total return

-44.7%

Start / end P/E

n/dx → n/dx

EPS bridge

1.09 → n/d

Residual

-46.7%

EPS growthn/d
Multiple reratingn/d
Dividend+1.9%
Residual / FX / buybacks / cross-term-46.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.